Abstract:Background: Cyclic guanosine monophosphate (cGMP) is the common second messenger for the cardiovascular effects of nitric oxide (NO) and natriuretic peptides, such as atrial or brain natriuretic peptide, which activate the soluble and particulate forms of guanylyl cyclase, respectively. However, natriuretic peptides and NO donors exert different effects on cardiac and vascular smooth muscle function. We therefore tested whether these differences are due to an intracellular compartmentation of cGMP and evaluated the role of phosphodiesterase (PDE) subtypes in this process. Methods and results: Subsarcolemmal cGMP signals were monitored in adult rat cardiomyocytes by expression of the rat olfactory cyclic nucleotide-gated (CNG) channel alpha-subunit and recording of the associated cGMP-gated current (ICNG). Atrial natriuretic peptide (10 nmol/L) or brain natriuretic peptide (10 nmol/L) induced a clear activation of ICNG, whereas NO donors (S-nitroso-N-acetyl-penicillamine, diethylamine NONOate, 3-morpholinosydnonimine, and spermine NO, all at 100 micromol/L) had little effect. The ICNG current was strongly potentiated by nonselective PDE inhibition with isobutyl methylxanthine (100 micromol/L) and by the PDE2 inhibitors erythro-9-(2-hydroxy-3-nonyl)adenine (10 micromol/L) and Bay 60-7550 (50 nmol/L). Surprisingly, sildenafil, a PDE5 inhibitor, produced a dose-dependent increase of I(CNG) activated by NO donors but had no effect (at 100 nmol/L) on the current elicited by atrial natriuretic peptide. Conclusions: These results indicate that in rat cardiomyocytes (1) the particulate cGMP pool is readily accessible at the plasma membrane, whereas the soluble pool is not; and (2) PDE5 controls the soluble but not the particulate pool, whereas the latter is under the exclusive control of PDE2. Differential spatiotemporal distributions of cGMP may therefore contribute to the specific effects of natriuretic peptides and NO donors on cardiac function.

Stimulation of guanylyl cyclase-D by bicarbonate.

Molecular Physiology of Membrane Guanylyl Cyclase Receptors

Guanylate cyclase-C receptor activation: unexpected biology

Antioxidants, Vitamin C and Dithiothreitol, Activate Membrane-Bound Guanylate Cyclase in PC12 Cells.

Proteolytic Activation of Membrane-Bound Guanylate Cyclase.

Calcium-sensor proteins but not bicarbonate ion activate retinal photoreceptor membrane guanylyl cyclase in photoreceptors

Activation Mechanism of Human Soluble Guanylate Cyclase by Stimulators and Activators

Nucleotidyl Cyclase Activity of Particulate Guanylyl Cyclase A: Comparison with Particulate Guanylyl Cyclases E and F, Soluble Guanylyl Cyclase and Bacterial Adenylyl Cyclases CyaA and Edema Factor.

Stimulation of Membrane-Bound Guanylate Cyclase Activity by 17-Β Estradiol

A Novel Insight into the Molecular Mechanism of Human Soluble Guanylyl Cyclase Focused on Catalytic Domain in Living Cells

Discovery of small molecule guanylyl cyclase A receptor positive allosteric modulators

[The Pharmacology of the GABA-induced Biphasic Response in Guinea-Pig Celiac Ganglion Neurons in Vitro].

cDNA Display Selection of Interacting Peptide Ligands of the Guanylate Cyclase C Receptor

Structural insights into the mechanism of human soluble guanylate cyclase

Structural Studies of the Periplasmic Portion of the Diguanylate Cyclase CdgH from Vibrio Cholerae

Probing the Molecular Mechanism of Human Soluble Guanylate Cyclase Activation by NO in Vitro and in Vivo

Architecture and activation of single-pass transmembrane receptor guanylyl cyclase

Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes

Efficient Expression of Human Soluble Guanylate Cyclase in Escherichia Coli and Its Signaling-Related Interaction with Nitric Oxide.

Structural basis for diguanylate cyclase activation by its binding partner in <i>Pseudomonas aeruginosa</i>

Allosteric Communication of the Dimerization and the Catalytic Domain in Photoreceptor Guanylate Cyclase